Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Renal function outcomes following liver transplantation and combined liver–kidney transplantation

Abstract

Acute renal failure (ARF) is common immediately after orthotopic liver transplantation (OLT), whereas the incidences of chronic kidney disease (CKD) and end-stage renal disease increase with time. Introduction of the Model for End-stage Liver Disease (MELD) score—intended to prioritize patients with more-severe pretransplantation liver disease in general, and worse pretransplantation renal function in particular—for the allocation of liver grafts led to concerns about compromised patient and allograft survival and increased incidence of postoperative ARF and CKD. Nonetheless, it has been suggested that early OLT of candidates with baseline renal dysfunction improves post-transplantation renal outcomes. For OLT candidates with mild to moderate chronic renal impairment or recent-onset ARF, the decision of whether to perform OLT alone or combined liver–kidney transplantation (CLKT) can be challenging because no single factor has been shown to be predictive of the degree of renal function recovery or CKD progression following successful OLT. In this article, we provide an overview of the literature on renal function outcomes following OLT and CLKT, share our perspectives on the potential predictors of renal dysfunction or nonrecovery of renal function after OLT, and present United Network for Organ Sharing data on patient and allograft outcomes in CLKT recipients in the pre-MELD and post-MELD eras. Mechanisms that might underlie immunological protection of kidney grafts by liver allografts are also discussed.

Key Points

  • Studies of renal function after orthotopic liver transplantation (OLT) have yielded conflicting results, and there is a paucity of data on renal outcomes after combined liver–kidney transplantation (CLKT)

  • The Model for End-stage Liver Disease (MELD) score, introduced in February 2002 for allocation of organs available for OLT, prioritizes patients with more-severe pretransplantation liver disease in general, and worse pretransplantation renal function in particular

  • More CLKTs have been performed, in both absolute and relative terms, since the introduction of the MELD score

  • Evidence indicates that liver allografts have an immunoprotective effect on kidney allografts from the same donor when the organs are transplanted together

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Survival of patients who underwent combined liver–kidney transplantation between 2000 and 2004
Figure 2: Survival of kidney grafts transplanted during combined liver–kidney transplantation between 2000 and 2004
Figure 3: Survival of liver grafts transplanted during combined liver–kidney transplantation between 2000 and 2004

Similar content being viewed by others

References

  1. Gonwa TA et al. (2006) Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant 6: 2651–2659

    Article  CAS  Google Scholar 

  2. Pawarode A et al. (2003) Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 9: 741–747

    Article  Google Scholar 

  3. Cohen AJ et al. (2002) Chronic renal dysfunction late after liver transplantation. Liver Transpl 8: 916–921

    Article  Google Scholar 

  4. Campbell MS et al. (2005) Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl 11: 1048–1055

    Article  Google Scholar 

  5. Marik PE et al. (2006) The course of type 1 hepatorenal syndrome post liver transplantation. Nephrol Dial Transplant 21: 478–482

    Article  Google Scholar 

  6. Pham PT et al. (2007) The impact of pre-transplant renal dysfunction on renal function outcomes after orthotopic liver transplant [abstract]. Presented at the World Congress of Nephrology: 2007 April 21–25, Rio de Janeiro, Brazil

  7. Machicao VI et al. (2006) Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Liver Transpl 12: 754–761

    Article  Google Scholar 

  8. Davis C (2006) Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Liver Transpl 12: 707–709

    Article  Google Scholar 

  9. Cabazuelo JB et al. (2004) Risk factors of acute renal failure after liver transplantation. Kidney Int 69: 1073–1080

    Article  Google Scholar 

  10. Alessandria C et al. (2005) MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 41: 1282–1289

    Article  Google Scholar 

  11. Pham PT et al. (2005) Review article: current management of renal dysfunction in the cirrhotic patient. Aliment Pharmacol Ther 21: 949–961

    Article  Google Scholar 

  12. Pham PT et al. Kidney dysfunction in the recipients of liver transplants. In Critical Care Nephrology (Eds Kellum JA and Ronco C) London: Elsevier (in press)

  13. Davis C (2005) Impact of pretransplant renal failure: when is listing for kidney-liver indicated? Liver Transpl 11 (Suppl 1): S35–S44

    Article  Google Scholar 

  14. Gonwa T (2005) Combined kidney liver transplant in the MELD era: where are we going? Liver Transpl 11: 1022–1025

    Article  Google Scholar 

  15. Pham PT et al. (2005) Renal failure in the adult renal transplant recipients. In Transplantation of the Liver, edn 2 891–916 (Eds Busuttil RW and Klintmam B) Philadelphia: Elsevier Saunders

    Chapter  Google Scholar 

  16. Ueno T et al. (2006) Liver and kidney transplantation for polycystic liver and kidney: renal function and outcome. Transplantation 82: 501–507

    Article  CAS  Google Scholar 

  17. United Network for Organ Sharing. Combined liver-kidney transplants performed between 1995–2004. [http://www.unos.org/helpSaveALife/] (accessed 22 June 2007)

  18. Rasmussen A et al. (1995) Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 59: 919–921

    Article  CAS  Google Scholar 

  19. Eid A et al. (1990) Evidence that the liver does not always protect the kidney from hyperacute rejection in combined liver and kidney transplantation across a positive lymphocyte crossmatch. Transplantation 50: 331–334.

    CAS  PubMed  Google Scholar 

  20. Katznelson S and Cecka JM (1996) The liver neither protects the kidney from rejection nor improves kidney graft survival after combined liver kidney transplantation from the same donor. Transplantation 61: 1403–1405

    Article  CAS  Google Scholar 

  21. Mjörnstedt L et al. (1997) Combined liver and kidney transplantation against a positive cross match in a patient with multispecific HLA-antibodies. Transplant Proc 29: 3164–3165

    Article  Google Scholar 

  22. Morrisey PE et al. (1998) Combined liver-kidney transplantation in patients with cirrhosis and renal failure: effect of a positive crossmatch and benefits of combined transplantation. Liver Transpl Surg 4: 363–369

    Article  Google Scholar 

  23. Pollack MS (2003) The very rapid loss of donor specific antibodies from the circulation after liver transplantation allows successful kidney transplantation from the same donor for even the most highly sensitized patients [abstract]. Hum Immunol 64 (Suppl 1): S62

    Article  Google Scholar 

  24. Gutierrez A et al. (2003) Outcomes of simultaneous liver-kidney transplantation in highly sensitized, cross-match positive patients. Transplant Proc 35: 1861–1862

    Article  CAS  Google Scholar 

  25. Gugenheim J et al. (1990) Specific absorption of lymphocytotoxic alloantibodies by the liver in inbred rats. Transplantation 50: 309–313

    Article  CAS  Google Scholar 

  26. Simpson N et al. (2006) Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: analysis of UNOS database. Transplantation 82: 1298–1303

    Article  Google Scholar 

  27. Olausson M et al. (2007) Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant 7: 130–136

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are indebted to Ms Katarina Anderson for providing the OPTN/UNOS data. This work was supported in part by Health Resources and Services Administration contract 234-2005-370011C. The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Health and Human services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alan H Wilkinson.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pham, PT., Pham, PC. & Wilkinson, A. Renal function outcomes following liver transplantation and combined liver–kidney transplantation. Nat Rev Nephrol 3, 507–514 (2007). https://doi.org/10.1038/ncpneph0574

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0574

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing